TY - JOUR
T1 - Effective elimination of cancer stem cells by magnetic hyperthermia
AU - Sadhukha, Tanmoy
AU - Niu, Lin
AU - Wiedmann, Timothy Scott
AU - Panyam, Jayanth
PY - 2013/4/1
Y1 - 2013/4/1
N2 - Cancer stem cells (CSCs) are a subpopulation of cancer cells that have stem cell-like properties and are thought to be responsible for tumor drug resistance and relapse. Therapies that can effectively eliminate CSCs will, therefore, likely inhibit tumor recurrence. The objective of our study was to determine the susceptibility of CSCs to magnetic hyperthermia, a treatment that utilizes superparamagnetic iron oxide nanoparticles placed in an alternating magnetic field to generate localized heat and achieve selective tumor cell kill. SPIO NPs having a magnetite core of 12 nm were used to induce magnetic hyperthermia in A549 and MDA-MB-231 tumor cells. Multiple assays for CSCs, including side population phenotype, aldehyde dehydrogenase expression, mammosphere formation, and in vivo xenotransplantation, indicated that magnetic hyperthermia reduced or, in some cases, eliminated the CSC subpopulation in treated cells. Interestingly, conventional hyperthermia, induced by subjecting cells to elevated temperature (46 C) in a water bath, was not effective in eliminating CSCs. Our studies show that magnetic hyperthermia has pleiotropic effects, inducing acute necrosis in some cells while stimulating reactive oxygen species generation and slower cell kill in others. These results suggest the potential for lower rates of tumor recurrence after magnetic hyperthermia compared to conventional cancer therapies.
AB - Cancer stem cells (CSCs) are a subpopulation of cancer cells that have stem cell-like properties and are thought to be responsible for tumor drug resistance and relapse. Therapies that can effectively eliminate CSCs will, therefore, likely inhibit tumor recurrence. The objective of our study was to determine the susceptibility of CSCs to magnetic hyperthermia, a treatment that utilizes superparamagnetic iron oxide nanoparticles placed in an alternating magnetic field to generate localized heat and achieve selective tumor cell kill. SPIO NPs having a magnetite core of 12 nm were used to induce magnetic hyperthermia in A549 and MDA-MB-231 tumor cells. Multiple assays for CSCs, including side population phenotype, aldehyde dehydrogenase expression, mammosphere formation, and in vivo xenotransplantation, indicated that magnetic hyperthermia reduced or, in some cases, eliminated the CSC subpopulation in treated cells. Interestingly, conventional hyperthermia, induced by subjecting cells to elevated temperature (46 C) in a water bath, was not effective in eliminating CSCs. Our studies show that magnetic hyperthermia has pleiotropic effects, inducing acute necrosis in some cells while stimulating reactive oxygen species generation and slower cell kill in others. These results suggest the potential for lower rates of tumor recurrence after magnetic hyperthermia compared to conventional cancer therapies.
KW - aldehyde dehydrogenase
KW - cancer stem cells
KW - clonogenicity
KW - magnetic hyperthermia
KW - mammosphere
KW - necrosis
KW - reactive oxygen species
KW - superparamagnetic iron oxide
KW - tumorigenicity
UR - http://www.scopus.com/inward/record.url?scp=84875797745&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875797745&partnerID=8YFLogxK
U2 - 10.1021/mp400015b
DO - 10.1021/mp400015b
M3 - Article
C2 - 23432410
AN - SCOPUS:84875797745
SN - 1543-8384
VL - 10
SP - 1432
EP - 1441
JO - Molecular pharmaceutics
JF - Molecular pharmaceutics
IS - 4
ER -